Strategic partnerships Leverage BOL Pharma's established collaboration with the Israeli Ministry of Health and its global pharmaceutical API/formulation capabilities to position co-development, white-label, or contract manufacturing partnerships with pharma, biotech, and medical cannabis companies seeking compliant GMP/API supply.

Global manufacturing Highlight BOL Pharma’s full-service contract manufacturing footprint, GAP-certified growing facilities, and cGMP production to target international buyers seeking reliable sourcing for pharma-grade cannabinoids, APIs, and finished dosage forms.

Clinical research focus Target CROs and clinical trial sponsors with BOL’s API and formulation capabilities for cannabis-based medical products, emphasizing support for clinical research, regulatory compliance, and scalable production for trial needs.

Regulatory credibility Emphasize the governmental license, certifications (GAP, cGMP), and Israel-based provenance to attract partners and customers prioritizing compliance, quality, and traceability in regulated markets.

Growth potential Position BOL Pharma’s growth story around access to a 99% pure pharma-grade cannabinoid supply, international patient reach, and recent partnerships to pursue new market opportunities in pharma, nutraceuticals, and cosmetics through white-label and contract manufacturing.